GSA Capital Partners’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $818K | Sell |
238,539
-28,356
| -11% | -$97.2K | 0.06% | 584 |
|
|
2025
Q1 | $595K | Sell |
266,895
-322,318
| -55% | -$719K | 0.05% | 675 |
|
|
2024
Q4 | $1.73M | Buy |
589,213
+347,347
| +144% | +$1.02M | 0.13% | 128 |
|
|
2024
Q3 | $629K | Buy |
241,866
+219,703
| +991% | +$571K | 0.05% | 762 |
|
|
2024
Q2 | $66K | Sell |
22,163
-63,957
| -74% | -$190K | ﹤0.01% | 1554 |
|
|
2024
Q1 | $390K | Sell |
86,120
-264,550
| -75% | -$1.2M | 0.03% | 1061 |
|
|
2023
Q4 | $2M | Buy |
350,670
+204,480
| +140% | +$1.17M | 0.17% | 117 |
|
|
2023
Q3 | $672K | Buy |
146,190
+135,504
| +1,268% | +$623K | 0.06% | 615 |
|
|
2023
Q2 | $69K | Buy |
+10,686
| New | +$69K | 0.01% | 1403 |
|
|
2023
Q1 | – | Sell |
-111,894
| Closed | -$1.13M | – | 1431 |
|
|
2022
Q4 | $1.13M | Buy |
+111,894
| New | +$1.13M | 0.14% | 157 |
|
|
2022
Q3 | – | Sell |
-68,466
| Closed | -$729K | – | 1463 |
|
|
2022
Q2 | $729K | Buy |
68,466
+51,478
| +303% | +$548K | 0.11% | 283 |
|
|
2022
Q1 | $166K | Buy |
+16,988
| New | +$166K | 0.02% | 1215 |
|